Sceroderma

Scleroderma is a rare autoimmune disease that leads to abnormal collagen production, causing skin thickening and fibrosis of internal organs. The condition is categorized into localized and systemic forms. Localized scleroderma primarily affects the skin, while systemic sclerosis can impact internal organs such as the lungs, kidneys, and gastrointestinal tract. Symptoms include skin tightening, Raynaud’s phenomenon, joint pain, and difficulty swallowing. In severe cases, pulmonary fibrosis and renal crisis can develop, leading to life-threatening complications.

Dr. Naval Mendiratta highlights the importance of a multidisciplinary approach in managing scleroderma, as it affects multiple organs. Treatment focuses on symptom control, as there is no cure for the disease. Immunosuppressive drugs, vasodilators, and physical therapy play a crucial role in improving quality of life. Regular monitoring of lung and kidney function is essential for early detection of complications. Patients are advised to maintain a healthy lifestyle, practice skin care, and avoid triggers that can worsen Raynaud’s symptoms. With early intervention and tailored management, disease progression can be slowed, helping patients lead a better quality of life.